Search
for
Sort by
Research 571–600 of 1000+
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Acquired and inheritedhair disorders
- 9. Immunology and Genetics
- 875 Exploring the role of microRNAs in alopecia areata
- Nail Involvement inAutoimmune Bullous Disorders
- Modeling cell–cell communication for immune systems across space and time
- Nanomaterial-Based Therapy for Wound Healing
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- Commentary
- The alopecia areata phenotype is induced by the water avoidance stress test in <i>cchcr1</i>-deficient mice
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- Alopecia areata in a rhesus monkey (Macaca mulatta)
- Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease
- Alopecia areata
- 877 Small T antigen from a folliculotropic polyomavirus activates canonical Wnt/β-catenin signaling in vivo
- 874 Chromatin architectural protein CTCF controls epidermal barrier formation, hair follicle fate maintenance and suppresses inflammatory responses in the skin epithelium
- Influence of donor sources and culture media on the histo-morphological quality of human artificial skin models
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- Veterinary Pharmacology
- Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus
- 51223 A novel human disease model of alopecia areata to evaluate benefit of the DHODH inhibitor farudodstat
- 546 Epidermal growth factor receptor as a key regulator of the immune privilege
- Hair Follicle Disruption Facilitates Pathogenesis to UVB-Induced Cutaneous Inflammation and Basal Cell Carcinoma Development in Ptch+/− Mice
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- New Modalities in the Treatment of Refractory Alopecia Areata
- GENETIC CONTROL OF CYTOKINES